Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches

por Valent, Peter
Publicado 2007

BRD4: A BET(ter) target for the treatment of AML?

por Valent, Peter, Zuber, Johannes
Publicado 2014

Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

por Füreder, Wolfgang, Valent, Peter
Publicado 2020

PB2476: TARGETING OF BRD4 TO COUNTERACT CYTOKINE-INDUCED EXPRESSION OF PD-L1 AND PD-L2 ON VASCULAR, OSTEOBLASTIC AND STROMAL NICHE CELLS

por Filik, Yüksel, Bauer, Karin, Valent, Peter
Publicado 2023

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms

por Hoermann, Gregor, Greiner, Georg, Valent, Peter
Publicado 2015

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?

por Pleyer, Lisa, Valent, Peter, Greil, Richard
Publicado 2016

Mastocytosis, MCAS, and Related Disorders—Diagnosis, Classification, and Therapy

por Niedoszytko, Marek, Valent, Peter, Nedoszytko, Bogusław
Publicado 2021

The underestimated role of basophils in Ph(+) chronic myeloid leukaemia

por Valent, Peter, Horny, Hans‐Peter, Arock, Michel
Publicado 2018

Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia

por Berger, Angelika, Sexl, Veronika, Valent, Peter, Moriggl, Richard
Publicado 2014

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology

por Hoermann, Gregor, Greiner, Georg, Griesmacher, Andrea, Valent, Peter
Publicado 2020

In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells

por Gamperl, Susanne, Stefanzl, Gabriele, Willmann, Michael, Valent, Peter, Hadzijusufovic, Emir
Publicado 2020

Evaluation of in vitro effects of various targeted drugs on plasma cells and putative neoplastic stem cells in patients with multiple myeloma

por Blatt, Katharina, Herrmann, Harald, Stefanzl, Gabriele, Sperr, Wolfgang R., Valent, Peter
Publicado 2016

E- and P-Selectins Are Essential for Repopulation of Chronic Myelogenous and Chronic Eosinophilic Leukemias in a Scid Mouse Xenograft Model

por Wicklein, Daniel, Schmidt, Anna, Labitzky, Vera, Ullrich, Sebastian, Valent, Peter, Schumacher, Udo
Publicado 2013

Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cell...

por Bauer, Karin, Berger, Daniela, Zielinski, Christoph C., Valent, Peter, Grunt, Thomas W.
Publicado 2018

Therapeutic Vulnerabilities in FLT3-Mutant AML Unmasked by Palbociclib

por Uras, Iris Z., Maurer, Barbara, Nebenfuehr, Sofie, Zojer, Markus, Valent, Peter, Sexl, Veronika
Publicado 2018

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis

por Brockow, Knut, Plata-Nazar, Katarzyna, Lange, Magdalena, Nedoszytko, Bogusław, Niedoszytko, Marek, Valent, Peter
Publicado 2021

Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022

por Valent, Peter, Hartmann, Karin, Bonadonna, Patrizia, Niedoszytko, Marek, Triggiani, Massimo, Arock, Michel, Brockow, Knut
Publicado 2022

The Transcription Factor MAZR Preferentially Acts as a Transcriptional Repressor in Mast Cells and Plays a Minor Role in the Regulation of Effector Functions in Response to FcεRI S...

por Abramova, Anastasia, Sakaguchi, Shinya, Schebesta, Alexandra, Hassan, Hammad, Boucheron, Nicole, Valent, Peter, Roers, Axel, Ellmeier, Wilfried
Publicado 2013